A 28-year-old man with schizophrenia and substance abuse history died from clozapine overdose. Key clinical failures included: inadequate assessment of suicide risk when prescribing one month's supply to a patient presenting sedated and under substance influence with recent non-compliance history; lack of recognition that the patient was in a high-risk period following care transfer between mental health services; ED doctor inappropriately prescribed clozapine without contacting the patient's mental health service despite knowing of psychiatric history and psychotic presentation; no communication between ED and mental health service regarding the patient's ED visit three days before death; and insufficient frequency of follow-up appointments considering the patient's risk factors, history of medication non-compliance, and ability to stockpile tablets through dose reduction habits.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
Inadequate safety assessment before dispensing one month's supply of clozapine to patient at high suicide risk
Failure to recognise high-risk period following transfer between mental health services
ED doctor prescribed clozapine without contacting patient's mental health service despite awareness of psychiatric history
No communication between ED and mental health services
Insufficient follow-up frequency in initial weeks after care transfer
Patient's ability to stockpile clozapine through dose reduction and non-compliance habits
Patient presenting sedated and under substance influence at initial assessment
No risk assessment of self-administration capability at time of transfer
Appointment scheduling based on clozapine protocol rather than individual patient needs
Coroner's recommendations
SHMHS and PHMHS review existing policies and procedures related to clozapine to address management of patients' own medication supplies at point of transfer and change from one brand of clozapine to another
Peninsula Health include information on restrictions of clozapine prescribing in training and orientation of all medical officers to decrease risk of inappropriate and unsafe patient access to clozapine
PHMHS review guidelines to increase frequency of review of clozapine patients in initial weeks following transfer from another mental health service, recognizing this as a high-risk period
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —